Detalhe da pesquisa
1.
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study.
Eur J Neurol
; 29(4): 1198-1208, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34826192
2.
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
Eur J Neurol
; 29(12): 3611-3622, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36083713
3.
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study.
Muscle Nerve
; 57(2): 212-216, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28342179
4.
Influence of cigarette smoking on ALS outcome: a population-based study.
J Neurol Neurosurg Psychiatry
; 87(11): 1229-1233, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27656044
5.
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report.
Acta Derm Venereol
; 101(5): adv00452, 2021 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846760
6.
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study).
Neurol Sci
; 41(Suppl 2): 487-488, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32845481
7.
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
J Neurol
; 271(5): 2434-2443, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38231271
8.
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience.
J Neurol
; 269(11): 5848-5857, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763113
9.
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
J Neurol
; 271(5): 2444-2445, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38564057
10.
Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.
JAMA Neurol
; 74(9): 1097-1104, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28692730
11.
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study.
Amyotroph Lateral Scler Frontotemporal Degener
; 18(7-8): 590-597, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28616937
12.
Droplet Digital PCR Assay for MYD88 L265P : Clinical Applications in Waldenström Macroglobulinemia.
Hemasphere
; 4(1): e324, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072140
13.
NADPH oxidase (NOX2) activity is a modifier of survival in ALS.
J Neurol
; 261(11): 2178-83, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25178511
14.
Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
Neurology
; 83(12): 1067-74, 2014 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122207
15.
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
JAMA Neurol
; 71(9): 1134-42, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25048026
16.
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome?
Amyotroph Lateral Scler Frontotemporal Degener
; 16(3-4): 274-6, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24920472
17.
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene.
J Neurol
; 259(12): 2723-5, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22918453